LC
Lindbrook Capital Portfolio holdings
AUM $1.08B
1-Year Return
10.14%
This Quarter Return
-5.02%
1 Year Return
+10.14%
3 Year Return
+35.76%
5 Year Return
+141%
10 Year Return
–
AUM
$593M
AUM Growth
-$12M
(-2%)
Cap. Flow
+$22.4M
Cap. Flow
% of AUM
3.78%
Top 10 Holdings %
Top 10 Hldgs %
49.61%
Holding
3,071
New
350
Increased
1,339
Reduced
784
Closed
167
Top Buys
| 1 |
RPAR Risk Parity ETF
RPAR
|
+$4.61M |
| 2 |
Golub Capital BDC
GBDC
|
+$3.18M |
| 3 |
Oaktree Specialty Lending
OCSL
|
+$2.74M |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$2.52M |
| 5 |
Vanguard Total Stock Market ETF
VTI
|
+$2.23M |
Top Sells
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$928K |
| 2 |
Vanguard Value ETF
VTV
|
+$665K |
| 3 |
Kinder Morgan
KMI
|
+$658K |
| 4 |
Nike
NKE
|
+$596K |
| 5 |
Intercontinental Exchange
ICE
|
+$519K |
Sector Composition
| 1 | Financials | 19.66% |
| 2 | Technology | 11.68% |
| 3 | Healthcare | 5.38% |
| 4 | Consumer Discretionary | 4.17% |
| 5 | Energy | 3.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PPBI
1851
DELISTED
Pacific Premier Bancorp
PPBI
| $3K | ﹤0.01% |
95
| – | – |
|
1852
Paysafe
PSFE
$820M
| $3K | ﹤0.01% |
181
+180
| +18,000% | +$2.98K |
|
1853
Quanterix
QTRX
$243M
| $3K | ﹤0.01% |
+229
| New | +$3K |
|
1854
Ryman Hospitality Properties
RHP
$6.19B
| $3K | ﹤0.01% |
47
+1
| +2% | +$64 |
|
1855
RLI Corp
RLI
$5.96B
| $3K | ﹤0.01% |
52
+20
| +63% | +$1.15K |
|
1856
Rogers Corp
ROG
$1.48B
| $3K | ﹤0.01% |
11
+5
| +83% | +$1.36K |
|
1857
Tandem Diabetes Care
TNDM
$846M
| $3K | ﹤0.01% |
56
+7
| +14% | +$375 |
|
1858
Adicet Bio
ACET
$67.9M
| $3K | ﹤0.01% |
187
+169
| +939% | +$2.71K |
|
|
ADAP
1859
Adaptimmune Therapeutics
ADAP
$21.5M
| $3K | ﹤0.01% |
3,084
+2,766
| +870% | +$2.69K |
|
1860
Adient
ADNT
$1.95B
| $3K | ﹤0.01% |
91
-72
| -44% | -$2.37K |
|
1861
First Majestic Silver
AG
$5.12B
| $3K | ﹤0.01% |
390
-231
| -37% | -$1.78K |
|
|
AGEN
1862
Agenus
AGEN
$145M
| $3K | ﹤0.01% |
63
+13
| +26% | +$619 |
|
1863
Agios Pharmaceuticals
AGIO
$2.13B
| $3K | ﹤0.01% |
112
+38
| +51% | +$1.02K |
|
1864
Assured Guaranty
AGO
$3.83B
| $3K | ﹤0.01% |
64
| – | – |
|
1865
Assurant
AIZ
$10.4B
| $3K | ﹤0.01% |
21
| – | – |
|
1866
Amerant Bancorp
AMTB
$860M
| $3K | ﹤0.01% |
118
+2
| +2% | +$51 |
|
1867
Artisan Partners
APAM
$3.19B
| $3K | ﹤0.01% |
96
+21
| +28% | +$656 |
|
1868
Arcutis Biotherapeutics
ARQT
$2.03B
| $3K | ﹤0.01% |
138
+12
| +10% | +$261 |
|
1869
AptarGroup
ATR
$8.84B
| $3K | ﹤0.01% |
36
-2
| -5% | -$167 |
|
1870
AvePoint
AVPT
$3.3B
| $3K | ﹤0.01% |
+781
| New | +$3K |
|
1871
Avnet
AVT
$4.45B
| $3K | ﹤0.01% |
72
| – | – |
|
1872
Axos Financial
AX
$5B
| $3K | ﹤0.01% |
79
| – | – |
|
|
AZUL
1873
DELISTED
Azul
AZUL
| $3K | ﹤0.01% |
376
+111
| +42% | +$886 |
|
1874
Bloom Energy
BE
$16.9B
| $3K | ﹤0.01% |
172
+5
| +3% | +$87 |
|
1875
Beam Therapeutics
BEAM
$2.3B
| $3K | ﹤0.01% |
60
+38
| +173% | +$1.9K |
|